These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1017 related items for PubMed ID: 16448580

  • 1. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME, Wiborg O, Mnie-Filali O, Benturquia N, Sánchez C, Haddjeri N.
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [Abstract] [Full Text] [Related]

  • 2. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.
    Chen F, Larsen MB, Sánchez C, Wiborg O.
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):193-8. PubMed ID: 15695064
    [Abstract] [Full Text] [Related]

  • 3. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O, El Mansari M, Scarna H, Zimmer L, Sánchez C, Haddjeri N.
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [Abstract] [Full Text] [Related]

  • 4. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C, Bergqvist PB, Brennum LT, Gupta S, Hogg S, Larsen A, Wiborg O.
    Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse.
    Jacobsen JP, Plenge P, Sachs BD, Pehrson AL, Cajina M, Du Y, Roberts W, Rudder ML, Dalvi P, Robinson TJ, O'Neill SP, Khoo KS, Morillo CS, Zhang X, Caron MG.
    Psychopharmacology (Berl); 2014 Dec; 231(23):4527-40. PubMed ID: 24810106
    [Abstract] [Full Text] [Related]

  • 8. Protein Kinases Alter the Allosteric Modulation of the Serotonin Transporter In Vivo and In Vitro.
    Mnie-Filali O, Lau T, Matthaeus F, Abrial E, Delcourte S, El Mansari M, Pershon A, Schloss P, Sánchez C, Haddjeri N.
    CNS Neurosci Ther; 2016 Aug; 22(8):691-9. PubMed ID: 27171685
    [Abstract] [Full Text] [Related]

  • 9. Allosteric effects of R- and S-citalopram on the human 5-HT transporter: evidence for distinct high- and low-affinity binding sites.
    Plenge P, Gether U, Rasmussen SG.
    Eur J Pharmacol; 2007 Jul 12; 567(1-2):1-9. PubMed ID: 17499240
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI/VFL-SI/TT mutant.
    Zhong H, Hansen KB, Boyle NJ, Han K, Muske G, Huang X, Egebjerg J, Sánchez C.
    Neurosci Lett; 2009 Oct 25; 462(3):207-12. PubMed ID: 19616061
    [Abstract] [Full Text] [Related]

  • 17. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.
    Owens MJ, Knight DL, Nemeroff CB.
    Biol Psychiatry; 2001 Sep 01; 50(5):345-50. PubMed ID: 11543737
    [Abstract] [Full Text] [Related]

  • 18. Mouse strain differences in SSRI sensitivity correlate with serotonin transporter binding and function.
    Jin ZL, Chen XF, Ran YH, Li XR, Xiong J, Zheng YY, Gao NN, Li YF.
    Sci Rep; 2017 Aug 17; 7(1):8631. PubMed ID: 28819255
    [Abstract] [Full Text] [Related]

  • 19. Allosteric modulation of the effects of the 5-HT reuptake inhibitor escitalopram on the rat hippocampal synaptic plasticity.
    Mnie-Filali O, El Mansari M, Espana A, Sànchez C, Haddjeri N.
    Neurosci Lett; 2006 Feb 27; 395(1):23-7. PubMed ID: 16330146
    [Abstract] [Full Text] [Related]

  • 20. Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors.
    Hjorth S, Auerbach SB.
    Eur J Pharmacol; 1994 Aug 01; 260(2-3):251-5. PubMed ID: 7988652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.